Clinical Trials Browser

Phase 2 × 3-fluorobenzylguanidine × 90 days × Clear all

NCT06858501 2025-12-31

Comparing 123I-MIBG and 18F-MFBG Imaging in Patients With Newly Diagnosed, High Risk Neuroblastoma

Phase 2 Not yet recruiting

Ganglioneuroblastoma